CC
IRWD icon

Clearline Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Clearline Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-92,870
Closed -$383K – 126
2024
Q3 		$383K Hold
92,870
– – 0.02% 133
2024
Q2 		$606K Hold
92,870
– – 0.02% 128
2024
Q1 		$809K Buy
+92,870
New +$1.13M 0.04% 106
2016
Q1 		– Sell
-172,447
Closed -$1.67M – 46
2015
Q4 		$1.67M Buy
+172,447
New +$1.67M 0.26% 46

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Clearline Capital's IRWD Position: Q4 2024 in Review

Clearline Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 92,870 shares — an estimated $383K sold.

Clearline Capital first reported a position in IRWD in Q4 2015 and held it in 4 quarters. The position peaked at $1.67M in Q4 2015. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.

  • Clearline Capital reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Clearline Capital sold 92,870 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $383K.
  • Clearline Capital first reported a position in Ironwood Pharmaceuticals in Q4 2015 and held it in 4 quarters.
  • Clearline Capital's Ironwood Pharmaceuticals position peaked at $1.67M in Q4 2015.
  • 223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.

Based on Clearline Capital's 13F filing for Q4 2024, filed 14 Feb 2025.